Goldman Sachs’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$64.8K Sell
6,172
-4,728
-43% -$46.1K ﹤0.01% 6268
2025
Q4
$125K Buy
10,900
+1,427
+15% +$22K ﹤0.01% 6155
2025
Q3
$230K Sell
9,473
-9,261
-49% -$154K ﹤0.01% 5892
2025
Q2
$308K Buy
18,734
+6,364
+51% +$110K ﹤0.01% 5431
2025
Q1
$225K Sell
12,370
-5,837
-32% -$167K ﹤0.01% 5588
2024
Q4
$675K Sell
18,207
-4,531
-20% -$173K ﹤0.01% 5069
2024
Q3
$728K Sell
22,738
-10,235
-31% -$568K ﹤0.01% 4846
2024
Q2
$2.71M Buy
32,973
+18,449
+127% +$1.99M ﹤0.01% 3694
2024
Q1
$2.1M Sell
14,524
-15,144
-51% -$1.28M ﹤0.01% 3833
2023
Q4
$2.73M Buy
29,668
+4,091
+16% +$416K ﹤0.01% 3677
2023
Q3
$4.22M Buy
25,577
+11,255
+79% +$1.46M ﹤0.01% 3136
2023
Q2
$905K Buy
14,322
+2,336
+19% +$142K ﹤0.01% 4407
2023
Q1
$407K Sell
11,986
-662
-5% -$34.6K ﹤0.01% 4946
2022
Q4
$731K Sell
12,648
-18,938
-60% -$1.17M ﹤0.01% 4633
2022
Q3
$2.97M Buy
31,586
+4,192
+15% +$597K ﹤0.01% 3612
2022
Q2
$6.11M Buy
27,394
+6,773
+33% +$2.27M ﹤0.01% 2950
2022
Q1
$11.3M Buy
20,621
+13,367
+184% +$8.08M ﹤0.01% 2566
2021
Q4
$4.79M Sell
7,254
-6,986
-49% -$5.34M ﹤0.01% 3454
2021
Q3
$12M Sell
14,240
-68
-0.5% -$69K ﹤0.01% 2550
2021
Q2
$18.2M Buy
14,308
+3,434
+32% +$3.88M ﹤0.01% 2128
2021
Q1
$11.9M Sell
10,874
-1,495
-12% -$1.97M ﹤0.01% 2406
2020
Q4
$17.7M Sell
12,369
-2,286
-16% -$2.44M ﹤0.01% 1969
2020
Q3
$10.3M Sell
14,655
-4,903
-25% -$3.56M ﹤0.01% 2292
2020
Q2
$13.7M Buy
19,558
+1,950
+11% +$1.13M ﹤0.01% 2007
2020
Q1
$6.16M Buy
17,608
+13,258
+305% +$9.39M ﹤0.01% 2476
2019
Q4
$2.73M Sell
4,350
-6,226
-59% -$3.04M ﹤0.01% 3433
2019
Q3
$3.54M Buy
10,576
+9,749
+1,179% +$3.13M ﹤0.01% 3112
2019
Q2
$215K Buy
+827
New +$166K ﹤0.01% 4757
2018
Q2
Sell
-2,156
Closed -$315K 5681
2018
Q1
$315K Buy
+2,156
New +$365K ﹤0.01% 4758

Other funds holding CDLX